Mar­ket­ingRx roundup: Ar­cutis joins crowd­ed pso­ri­a­sis ad mar­ket on TV; Mer­ck, GSK, Mod­er­na high­light im­mu­niza­tion month

Ar­cutis is jump­ing in­to the pso­ri­a­sis TV ad mar­ket with its first-ever com­mer­cial for Zorvye, its non-steroid cream ap­proved in Ju­ly 2022. The mes­sage be­hind the ad called “The Cream That Can” is about mak­ing the top­i­cal man­age­ment of plaque pso­ri­a­sis sim­ple, the com­pa­ny said in a press re­lease.

The ad will air on lead­ing on-de­mand stream­ing ser­vices, aim­ing to reach many of the now more than 130 mil­lion com­mer­cial pa­tients who have ac­cess to Zo­ryve (rof­lu­mi­last), the bio­phar­ma said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER